Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Giovannini M et al. - In this paper the authors reviewed the current available data regarding the clinical significance of skin reaction due to EGFR targeted agents. The authors show that skin toxicity can be considered as predictive marker of response to such drugs and that it is not disease specific; however its potential prognostic value is still to be proven.

Related Articles

Incidence and Correlates of Radiation Dermatitis in Children and Adolescents Receiving Radiation Therapy for the Treatment of Paediatric Sarcomas
Clinical Oncology, 11/12/09    Relevance Score: 65%

Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different
Anti-Cancer Drugs, 10/19/09    Relevance Score: 65%

Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment
Best Practice & Research: Clinical Rheumatology, 10/28/09    Relevance Score: 64%

Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer
Journal of Clinical Oncology, 11/03/09    Relevance Score: 63%

Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis
Scandinavian Journal of Rheumatology, 10/08/09    Relevance Score: 63%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address